These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 36949309)

  • 1. C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders.
    Orsolini L; Pompili S; Volpe U
    Adv Exp Med Biol; 2023; 1411():135-160. PubMed ID: 36949309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein as a potential biomarker in psychiatric practice: Are we there yet?
    Baysak E; Guden DS; Aricioglu F; Halaris A
    World J Biol Psychiatry; 2022; 23(4):243-256. PubMed ID: 34323645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.
    Orsolini L; Sarchione F; Vellante F; Fornaro M; Matarazzo I; Martinotti G; Valchera A; Di Nicola M; Carano A; Di Giannantonio M; Perna G; Olivieri L; De Berardis D
    Curr Neuropharmacol; 2018; 16(5):583-606. PubMed ID: 29357805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Reactive Protein: Marker of risk for post-traumatic stress disorder and its potential for a mechanistic role in trauma response and recovery.
    Friend SF; Nachnani R; Powell SB; Risbrough VB
    Eur J Neurosci; 2022 May; 55(9-10):2297-2310. PubMed ID: 33131159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
    Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Associations Between C-Reactive Protein and Mood and Anxiety Symptoms in Adolescents.
    Liu Q; Ely BA; Simkovic S; Alonso CM; Gabbay V
    J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):404-410. PubMed ID: 34166062
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study.
    Liemburg EJ; Nolte IM; ; Klein HC; Knegtering H
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():89-94. PubMed ID: 29778547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and white blood cell levels in schizophrenia, bipolar disorders and depression - associations with mortality and psychiatric outcomes: a population-based study.
    Horsdal HT; Köhler-Forsberg O; Benros ME; Gasse C
    Eur Psychiatry; 2017 Jul; 44():164-172. PubMed ID: 28645055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, pre- and postdexamethasone cortisol levels in post-traumatic stress disorder.
    Spitzer C; Wibisono D; Terfehr K; Löwe B; Otte C; Wingenfeld K
    Nord J Psychiatry; 2014 Jul; 68(5):296-9. PubMed ID: 24134123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
    Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
    Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Reactive Protein as a Biomarker for Major Depressive Disorder?
    Orsolini L; Pompili S; Tempia Valenta S; Salvi V; Volpe U
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Biomarkers for Mood Disorders - A Brief Narrative Review.
    Chang HH; Chen PS
    Curr Pharm Des; 2020; 26(2):236-243. PubMed ID: 31939727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Elevated C-Reactive Protein and Manic Polarity in Acute Psychiatric Inpatients with Affective Symptomatology.
    Zohar N; Hochman E; Katz N; Krivoy A; Weizman A; Barzilay R
    Neuropsychobiology; 2017; 76(3):166-170. PubMed ID: 29902794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.